Skladanowski A, Konopa J
Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdańsk, Poland.
Biochem Pharmacol. 1994 Jun 15;47(12):2269-78. doi: 10.1016/0006-2952(94)90265-8.
Using a new mild method it is shown for two anthracyclines, Adriamycin and Daunomycin, that these compounds are able to form DNA crosslinks in HeLa S3 cells. It was also found that other anthracyclines: Epirubicin, Rubidazone, Iodorubicin, 3'-deamino-3'-hydroxy-4'-amino-Adriamycin, Aclacinomycin, Marcellomycin, and Cinerubin A, induced crosslinks in the DNA of HeLa S3 cells in a concentration-dependent manner. DNA crosslinks formed by five anthracyclines studied, excluding Iodorubicin, were both alkali and thermally unstable. No DNA crosslinking could be detected when the compounds were added to cell lysates in which cellular enzymes had been inactivated. This implies that metabolic activation is prerequisite for DNA crosslinking by anthracyclines. The kinetics of DNA crosslinks formation by Adriamycin as well as their removal from cellular DNA were also studied. The presented results indicate that all biologically active anthracyclines studied induce DNA crosslinks, and for two of them DNA crosslinking was observed at growth inhibitory concentrations.
使用一种新的温和方法,已证明对于两种蒽环类药物阿霉素和柔红霉素,这些化合物能够在HeLa S3细胞中形成DNA交联。还发现其他蒽环类药物:表柔比星、鲁比唑酮、伊达比星、3'-脱氨基-3'-羟基-4'-氨基阿霉素、阿克拉霉素、马塞洛霉素和西奈鲁宾A,以浓度依赖的方式在HeLa S3细胞的DNA中诱导交联。所研究的五种蒽环类药物(不包括伊达比星)形成的DNA交联在碱性和热条件下均不稳定。当将这些化合物添加到细胞酶已失活的细胞裂解物中时,未检测到DNA交联。这意味着代谢激活是蒽环类药物进行DNA交联的先决条件。还研究了阿霉素形成DNA交联的动力学以及它们从细胞DNA中的去除情况。所呈现的结果表明,所有研究的具有生物活性的蒽环类药物均能诱导DNA交联,并且其中两种在生长抑制浓度下观察到了DNA交联。